期刊
EXPERIMENTAL CELL RESEARCH
卷 358, 期 2, 页码 269-278出版社
ELSEVIER INC
DOI: 10.1016/j.yexcr.2017.07.004
关键词
CAV1; Sunitinib-resistance; Invasion; Prognosis; Diagnosis; ccRCC
资金
- National Natural Science Foundation of China [81672528, 81672524, 81272560]
- Department of Education of China [NCET-08-0223]
- National High Technology Research and Development Program of China (863 Program) [2012AA021101]
Caveolin-1 (CAV1) has been identified to be up-regulated in many cancers, including clear cell renal cell carcinoma (ccRCC). However, its potential function is still unclear in ccRCC. In this study, we demonstrated that CAV1 was frequently overexpressed in renal cell carcinoma tissues and cells, and was significantly associated with various clinicopathological parameters. In addition, high CAV1 expression was associated with poor disease-free survival (DFS) rate and could serve as a useful diagnostic indicator in ccRCC patients with different clinicopathological stages. Functional experiments demonstrated that CAV1 knockdown inhibited cell migration and invasion, whereas overexpression of CAV1 promoted cell migration and invasion in ccRCC. Moreover, CAV1 expression was up-regulated in sunitinib-resistant renal cancer cell lines, and its over-expression promoted sunitinib resistance. In general, our results confirm that CAV1 plays an important role in the metastasis of kidney cancer and induces sunitinib resistance, so CAV1 function suppression may become a promising clinical treatment strategy during renal cell carcinoma metastasis and sunitinib resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据